LOW-GRADE SEROUS OVARIAN CANCER
Clinical trials for LOW-GRADE SEROUS OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new LOW-GRADE SEROUS OVARIAN CANCER trials appear
Sign up with your email to follow new studies for LOW-GRADE SEROUS OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test new drug duo in fight against tough cancers
Disease control OngoingThis early-stage trial is testing the safety and best dose of a new two-drug combination for people with advanced solid tumors that have stopped responding to standard treatments. The study is focusing on specific cancers, including certain types of lung, ovarian, and pancreatic …
Matched conditions: LOW-GRADE SEROUS OVARIAN CANCER
Phase: PHASE1 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New drug duo targets Tough-to-Treat ovarian cancer
Disease control OngoingThis study is testing the safety and effectiveness of two oral drugs, avutometinib and defactinib, given together to Japanese patients with a specific type of recurrent ovarian cancer. The goal is to see if this combination can shrink tumors and control the cancer in patients who…
Matched conditions: LOW-GRADE SEROUS OVARIAN CANCER
Phase: PHASE2 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated Feb 20, 2026 14:36 UTC